12.12.2014 16:00:00 CET
Helsinki, 12 December 2014 at 5:00 pm
Nexstim Plc will publish the following financial information in 2015:
Nexstim Annual Report 2014 will be published on company web pages on Monday, March 9, 2015.
The Annual General Meeting is tentatively scheduled to be held on Tuesday, March 31, 2015 at 9:00 a.m.
Board of Directors
For further information please visit www.nexstim.com or contact:
| Nexstim |
Janne Huhtala, Chief Executive Officer
| 040 8615046 |
|UB Capital Oy (Certified Adviser)||09 2538 0225|
| Consilium Strategic Communications |
| +44 (0)20 3709 5700 |
Nexstim, formed in 2000 and based in Finland, is a medical technology company aiming to improve rehabilitation for stroke patients. Nexstim has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) device for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a device for stroke therapy called Navigated Brain Therapy (NBTŪ). In H1 2014, Nexstim initiated a two-year pivotal Phase III study at 12 sites in the US aiming to demonstrate the effectiveness of NBTŪ and gain FDA clearance for commercialisation in post-acute stroke therapy in the US. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com.